← Back to Search

ASMAS for Asthma (PeerASMAS Trial)

N/A
Waitlist Available
Led By Daphne Koinis-Mitchell, PhD
Research Sponsored by Rhode Island Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a novel intervention - ASMAS - which is specifically designed to help Latino middle school children with asthma manage their condition. The intervention will be delivered by trained high school students who also have asthma, and the trial will take place in Providence, RI and San Juan, PR.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in asthma control
Change in asthma related school absence ratio
Change in lung function
+1 more
Secondary study objectives
Change in asthma Action plan/Inhaler availability
Change in asthma self-management
Change in child asthma knowledge
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: ASMASExperimental Treatment1 Intervention
ASMAS is an asthma self-management program based on NHLBI clinical guidelines for optimal school-based asthma management. It involves 4, 1½ hour sessions delivered in group format in the urban, middle school setting by a Latino High School Peer who has asthma. ASMAS focuses on asthma pathophysiology, symptom management, asthma medications, and trigger control.
Group II: Asthma education plus child healthActive Control1 Intervention
Asthma Education plus Child Health control condition will be delivered by an adult Health Educator , and includes 4 sessions (1 1/2 hrs long) of our existing asthma education ("Asthma's Magic Number") with added general health topics (nutrition, physical activity, safety).
Group III: No Treatment ControlActive Control1 Intervention
Students randomly assigned to this arm , will receive standard of care, which is no treatment, and will not participate in any group intervention sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ASMAS
2019
N/A
~250

Find a Location

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor
262 Previous Clinical Trials
68,499 Total Patients Enrolled
10 Trials studying Asthma
3,182 Patients Enrolled for Asthma
University of Puerto RicoOTHER
66 Previous Clinical Trials
21,754 Total Patients Enrolled
2 Trials studying Asthma
884 Patients Enrolled for Asthma
Sheryl J Kopel, MScStudy DirectorRhode Island Hospital
~37 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top